Kenneth Dority
Family Medicine · Arlington, TXNPI 1659313328
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Corium, LLC at 29.0% of the total.
Across 175 payments — averaging $11.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$571
- Ironshore Pharmaceuticals Inc.$252
- Tris Pharma Inc$168
- Collegium Pharmaceutical, Inc.$164
- AbbVie$160
- Neos Therapeutics, LP$153
- plus $502 from 8 others
What the payments were for
- Food & beverage$1,94899%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 64 | $571 |
| Ironshore Pharmaceuticals Inc. | 32 | $252 |
| Tris Pharma Inc | 3 | $168 |
| Collegium Pharmaceutical, Inc. | 30 | $164 |
| AbbVie | 3 | $160 |
| Neos Therapeutics, LP | 18 | $153 |
| Noven Therapeutics, LLC | 8 | $131 |
| Alkermes, Inc. | 7 | $127 |
| Noven Pharmaceuticals, Inc. | 1 | $96 |
| Indivior Inc. | 5 | $76 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Orexo US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Quillivant$125
- Dyanavel XR$125
- Quillichew ER$125
- Mavyret$116
How this compares
$1,969 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $197 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Arlington
- Bradley WassonArlington$734K
- Gilbert LedesmaArlington$34K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.